SAN FRANCISCO (MarketWatch) -- Roche and GlaxoSmithKline Plc said late Friday the Food and Drug Administration has approved Boniva Injection, the first intravenous medication for the treatment of ...
(Reuters) - The first generic versions of Roche's bone-strengthening drug Boniva have been approved by the U.S. Food and Drug Administration. Boniva, known generically as ibandronate, is taken once a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results